scholarly journals OptoDyCE: Automated System for High-Throughput All-Optical Dynamic Cardiac Electrophysiology

2015 ◽  
Author(s):  
Aleksandra Klimas ◽  
Jinzhu Yu ◽  
Christina M. Ambrosi ◽  
John C. Williams ◽  
Harold Bien ◽  
...  

The improvement of preclinical cardiotoxicity testing, the discovery of new ion channel-targeted drugs, and the phenotyping and use of stem-cell-derived cardiomyocytes and other biologics all necessitate high-throughput (HT), cellular level electrophysiological interrogation tools. Optical techniques for actuation and sensing provide instant parallelism, enabling contactless dynamic HT testing of cells and small-tissue constructs, not affordable by other means. Here, we consider, computationally and experimentally, the limits of all-optical electrophysiology when applied to drug testing, then implement and validate OptoDyCE, a fully automated system for all-optical cardiac electrophysiology. We validate optical actuation by virally introducing optogenetic drivers in (rat and human) cardiomyocytes or through the modular use of dedicated light-sensitive somatic "spark" cells. We show that this automated all-optical approach provides high-throughput means of cellular interrogation, i.e. allows for dynamic testing of >600 multicellular samples or compounds per hour, and yields high-content information about the action of a drug over time, space and doses.

2016 ◽  
Vol 7 (1) ◽  
Author(s):  
Aleksandra Klimas ◽  
Christina M. Ambrosi ◽  
Jinzhu Yu ◽  
John C. Williams ◽  
Harold Bien ◽  
...  

2016 ◽  
Author(s):  
Aleksandra Klimas ◽  
Jinzhu Yu ◽  
Christina M. Ambrosi ◽  
John C. Williams ◽  
Harold Bien ◽  
...  

2021 ◽  
Vol 3 ◽  
pp. 100007
Author(s):  
Kathleen L. Miller ◽  
Yi Xiang ◽  
Claire Yu ◽  
Jacob Pustelnik ◽  
Jerry Wu ◽  
...  

2009 ◽  
Vol 3 (2) ◽  
pp. 108-114
Author(s):  
Jairam Palamanda ◽  
Xinjie Lin ◽  
Pramila Kumari ◽  
Amin Nomeir

Author(s):  
Silvia Sauleda ◽  
Lourdes Palacios ◽  
Vanessa Brès ◽  
Maria Piñana ◽  
Lorena Alonso-Hernandez ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (8) ◽  
pp. e0183761 ◽  
Author(s):  
Matthew T. McPheeters ◽  
Yves T. Wang ◽  
Andreas A. Werdich ◽  
Michael W. Jenkins ◽  
Kenneth R. Laurita

2015 ◽  
Vol 117 (suppl_1) ◽  
Author(s):  
Millie Shah ◽  
Cheryl Borgman ◽  
Kevin Janes

Latent coxsackievirus B3 (CVB3) cardiac infections are implicated in the development of DCM with persistent enteroviral RNA found in up to 66% (30/45) of DCM patient biopsies who are at a 6-fold higher risk of fatality. Current treatments aim at delaying heart failure but none address the viral etiology of the disease. Viral protein presence is thought to disrupt normal cellular signaling leading to tissue dysfunction. The downstream effects of viral perturbations are complex and wide-ranging; especially in proinflammatory contexts seen clinically. Thus, comprehensively understanding the molecular mechanisms of CVB3-mediated disease is key in developing treatments for viral DCM patients. In this study we built a novel in vitro model of chronic CVB3 infection to facilitate high-throughput, systems-level studies of viral cardiomyopathy. Current methods of studying CVB3 rely on animals or animal derived cardiac cells, making large-scale intracellular signaling studies difficult, time intensive, and expensive. To facilitate high-throughput studies we used immortalized human cardiomyocytes to engineer single-cell derived cell lines that express a maturation deficient CVB3 genome. CVB3 RNA expression was validated in each line by two independent methods: gene-specific nested qRT-PCR and single molecule RNA fluorescence in situ hydridization (smFISH). Plaque-assay verified that viral RNA expression did not result in live virus release. Microarray analysis shows that CVB3 expressing cell lines have altered immune cytokine, extracellular matrix protein, and stress-signaling protein expression. Further, differences between CVB3 expressing lines suggest differential responses to viral RNA expression which may identify a set of beneficial adaptations. Future studies will include high-throughput signaling protein activity assays we have developed specifically for phosphatase and kinase activity quantification with the aim of linking immune cytokine signaling dysregulation to pathogenic gene expression. These studies will deepen our knowledge of CVB3-mediated DCM and identify proteins whose targeted modulation could offer new treatment strategies to patients whose current options are either palliative care or heart transplantation.


Sign in / Sign up

Export Citation Format

Share Document